FDA Investigator

D'Arbra R Blankenship

Latest inspection on record: Kujawsko-Pomorskie, Poland, May 2026 · records back to 2021

Human DrugsMedical Devices & Rad HealthBiologicsAnimal Drugs & FeedsFoods & Cosmetics

FDA inspection record · Last updated July 12, 2026

Overview

  • 48 inspections across 46 sites are on record.
  • 5 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-22.

At a glance

Inspections

48

Sites

46

Observations

5

Career since

Oct 2021

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Rafal Wojciechowski, M.D., Ph.D.22 May 2026Human Drugs
Battelle Memorial Institute, BBRC7 May 2026Human Drugs
Bruce C. Trapnell M.D.10 Apr 2026Human Drugs
Nicolas S. Piuzzi, M.D.27 Mar 2026Human DrugsOn file
Lawrence W. Elmer, MD, PhD18 Feb 2026Human Drugs

Sites inspected

Rafal Wojciechowski, M.D., Ph.D.Kujawsko-Pomorskie, Poland1 insp.
Battelle Memorial Institute, BBRCWest Jefferson, United States1 insp.
Bruce C. Trapnell M.D.Cincinnati, United States1 insp.
Nicolas S. Piuzzi, M.D.Cleveland, United States1 insp.
Lawrence W. Elmer, MD, PhDToledo, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Craig T Rybus2 shared
Barbara D Wright1 shared
Zhou Chen1 shared
Hugh M Mcclure1 shared
Yiyue C Zhang1 shared

Full investigator report

Get the verbatim findings behind D'Arbra R Blankenship's 5 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators